Abstract
Schistosomiasis affects 200 to 250 million people worldwide. Hepatic schistosomiasis is a well-recognized cause of chronic liver disease and portal hypertension. There are no previous reports of schistosomiasis post liver transplantation. We report on 2 cases of schistosomiasis in liver transplant recipients--a case of gastric schistosomiasis and a case of hepatic schistosomiasis. A discussion of the pathology of schistosomal infection and a rationale for screening potential liver transplant recipients from endemic areas follows.
MeSH terms
-
Animals
-
Anthelmintics / therapeutic use
-
Antibodies, Helminth / analysis
-
Biopsy
-
Diagnosis, Differential
-
Follow-Up Studies
-
Humans
-
Liver / parasitology
-
Liver / pathology
-
Liver Diseases, Parasitic / drug therapy
-
Liver Diseases, Parasitic / etiology*
-
Liver Diseases, Parasitic / pathology
-
Liver Transplantation / adverse effects*
-
Male
-
Middle Aged
-
Praziquantel / therapeutic use
-
Schistosoma / immunology
-
Schistosomiasis mansoni / drug therapy
-
Schistosomiasis mansoni / etiology*
-
Schistosomiasis mansoni / pathology
Substances
-
Anthelmintics
-
Antibodies, Helminth
-
Praziquantel